期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

系统性红斑狼疮患者应用免疫抑制剂的妊娠结局及临床分析 被引量：3

下载PDF
导出
摘要 系统性红斑狼疮（SEE）好发于育龄期女性，是一种可累及全身多脏器损害的自身免疫病，糖皮质激素与免疫抑制剂是治疗SLE的主要药物。SLE病情活动可导致胎儿发育迟缓、流产、死胎、死产，危及母亲生命，妊娠也可诱发或加重SLE病情。本研究调查了SLE患者应用免疫抑制剂的妊娠结局，分析妊娠期间SLE病情恶化、不良妊娠结局的相关因素．为SLE患者妊娠期间接受合理的治疗方案提供理论依据。
作者 李玉翠 张莉芸 许珂
机构地区 山西医学科学院 山西大医院风湿免疫科
出处 《中国药物与临床》 CAS 2015年第4期525-528,共4页 Chinese Remedies & Clinics
关键词 系统性红斑狼疮患者 不良妊娠结局 免疫抑制剂 临床分析 应用 SLE患者 全身多脏器损害 胎儿发育迟缓
分类号 R714.25 [医药卫生—妇产科学]
  • 相关文献

参考文献9

  • 1Saavedra MA,Cruz-Reyes C,Vera-Lastra O,et al. Impact of pre- vious lupus nephritis on maternal and fetal outcomes during pregnancy [ J ]. Clin Rheumatol, 2012,31 (5) : 813-819.
  • 2Gladman DD,Tandon A,Ibanez D,et al. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complica- tions[J]. J Rheumatol,2010,37(4):754-758.
  • 3Costedoat-Chalumeau N, Dunogu6 B, Morel N, et al. Hydroxy- chloroquine:a multifaceted treatment in lupus[J]. Presse Med, 2014,43(6 Pt 2) :e167-180.
  • 4Braunstein I,Werth V. Treatment of dermatologic connective tis- sue disease and autoimmune blistering disorders in pregnancy [ J ]. Dermatol Ther, 20l 3,26 (4) : 354-363.
  • 5Ritchie J,Smyth A,Tower C,et al. Maternal deaths in women with lupus nephritis: a review of published evidenee[J]. Lupus, 2012,21(5) :534-541.
  • 6赵慧霞,王彩虹,罗静,张艳玲,刘国霞,栗江霞,李小峰.羟氯喹在系统性红斑狼疮治疗中的研究进展[J].中国药物与临床,2012,12(7):920-921. 被引量：14
  • 7Alarfaj AS, Khalil N. Fertility, ovarian failure, and pregnancy out- come in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia[J]. Clin Rheumatol, 2014,33 (12) : 1731-1736.
  • 8Peart E,Clowse ME. Systemic lupus erythematosus and pregnan- cy outcomes:an update and review of the literature [J]. CurrOpin Rheumatol, 2014,26 (2) : 118-123.
  • 9Cooper WO,Cheetham TC,Li DK,et al. Brief report:Risk of ad- verse fetal outcomes associated with immunosuppressive medica- tions for chronic immune-mediated diseases in pregnancy [J]. Arthritis Rheum,2014,66(2) :444-450.

二级参考文献11

  • 1Tanaka E,Taniguchi A,Urano W,et al. Pharmacogenetics of disease-modifying anti-rheumatic drugs. Best Pract Res Clin Rheumatol, 2004,18 : 233-247.
  • 2Hurst NP,French ]K,Gorjatsehko L,et al. Chloroquine and hy- droxychloroquine inhibit multiple sites in metabolic pathways leading to neutrophil superoxide release. J Rheumatol, 1988,15: 23-27.
  • 3Nowell J,Quaranta V. Chloroquine affects biosynthesis of ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimmers in B cells. J Exp Med, 1985,162:1371- 1376.
  • 4Fox R. Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development. Lupus, 1996,5 (Suppl 1 ) : S4-10.
  • 5Accapezzato D,Visco V,Francavilla V,et al. Chloroquine en- hances human CD8+ T cell responses against soluble antigens in vivo. J Exp Med,2005,202:817-828.
  • 6Garrett-Sinha LA,John S,Gaffen SL. IL-17 and the IL-17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol,2008,20 (5) ,519-525.
  • 7Lau CM,Broughton C,Tabor AS,et al. RNA-associated autoanti- gens activate B cells by combined B cell antigen receptor/toll- like receptor 7 engagement. J Exp Med, 2005,202 : 1171-1177.
  • 8Alarcon GS, McGwin G, Bertoli AM, et al. LUMINA Study Group. Effect of hydroxychloroquine on the survival of patients with sys- temic lupus erythematosus: data from the LUMINA,a muhieth- nic US cohort. Ann Rheum Dis,2007,66:1168-1172.
  • 9Siso A,Ramos-Casals M,Bove A,et al. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus, 2008,17 : 281-288.
  • 10Haehner T,Refaie MO,Mtiller-Enoch D. Drug-drug interactions evaluated by a highly active reconstituted native human cy- tochrome P4503A4 and human NADPH-cytochrome P450 reduc- tase system. Arzneimittelforschung, 2004,54: 78-83.

共引文献13

同被引文献58

引证文献3

二级引证文献13

中国药物与临床
2015年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部